FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082621 [Registered on: 18/03/2025] Trial Registered Prospectively
Last Modified On: 14/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare the efficacy of two nasal drops in two groups of patients with allergic rhinitis 
Scientific Title of Study   To compare the efficacy of Shigru taila nasya with Shadbindhu taila nasya in Vataja pratisyaya Nasal eosinophilia An open label double arm controlled clinical study 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sreerenjini S 
Designation  Postgraduate scholar Department of Shalakyatantra 
Affiliation  SDM Institue of Ayurveda and Hospital 
Address  SDM Institute of Ayurveda and Hospital Anchepalya Kumbalagodu Bengaluru
Department of PG studies in Shalakya tantra , SDM Institute of Ayurveda and Hospital Anchepalya Kumbalagodu Bengaluru , Post 560074
Bangalore Rural
KARNATAKA
560074
India 
Phone  8547883628  
Fax    
Email  sreerenjini5191@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mamatha K V 
Designation  Professor and HOD 
Affiliation  SDM Institue of Ayurveda and Hospital 
Address  Professor and HOD Department of Shalakya tantra SDM Institute Of Ayurveda and Hospital Anchepalya Kumalagodu Bengaluru
Professor and HOD Department pg studies in Shalakya tantra SDM Institute Of Ayurveda and Hospital Anchepalya Kumalagodu Bengaluru Post 560074
Bangalore Rural
KARNATAKA
560074
India 
Phone  9845393236  
Fax    
Email  mamatha.sova@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sreerenjini S 
Designation  Postgraduate scholar 
Affiliation  SDM Institue of Ayurveda and Hospital 
Address  SDM Institute of Ayurveda and Hospital Anchepalya Kumbalagodu Bengaluru
Department of PG studies in Shalaya tantra SDM Institute of Ayurveda and Hospital Anchepalya Kumbalagodu Bengaluru Post 560074
Bangalore Rural
KARNATAKA
560074
India 
Phone  8547883628  
Fax    
Email  sreerenjini5191@gmail.com  
 
Source of Monetary or Material Support  
SDM Institute of Ayurveda and Hospital Anchepalya Kumbalagodu Bengaluru 560074 
 
Primary Sponsor  
Name  Dr Sreerenjini S 
Address  SDM Institute Of Ayurveda and Hospital Anchepalya Kumbalagiodu Bengaluru 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sreerenjini S  SDM Institute Of Ayurveda and Hospital  SDM Institute of Ayurveda and Hospital Anchepalya Kumbalagodu Bengaluru
Bangalore Rural
KARNATAKA 
08547883628

sreerenjini5191@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional ethics committee , SDM Ayurveda and Hospital , Bengaluru  Approved 
Institutional ethics committee , SDM Ayurveda and Hospital , Bengaluru  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J309||Allergic rhinitis, unspecified. Ayurveda Condition: PRATISYAYAH/PINASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Shigru taila, Reference: Vnagasenasanhitha , Chikitsasara samgraha , Chapter 70, Route: Nasal, Dosage Form: Taila, Dose: 3(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -doing in Aparahna
2Comparator ArmDrugClassical(1) Medicine Name: Shadbindhu taila , Reference: Bhaishajya ratnavali , nasarogadhikara , chapter 65, Route: Nasal, Dosage Form: Taila, Dose: 3(ml), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -doing in Aparahna
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  1.Patients presenting lakshanas of Vataja Pratisyaya
2.Nasal eosinophilia confirmed through Nasal smear
3.Patient with chronicity less than 5years
4.Patients fit for Nasya karma 
 
ExclusionCriteria 
Details  1. Patients suffering from upper respiratory tract infections
2.Patients who have uncontrolled Diabetes mellitus and Hypertension
3.Patient having recent medical therapy for Eosinophilia
4.Patients having Migraine headaches , Gross DNS, Adenoditis and Tonsillitis 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Global improvement in the signs and symptoms of Vataja pratisyaya
Reduction of Eosinophil count in Nasal smear 
0th day ,8th day ,15th day 
 
Secondary Outcome  
Outcome  TimePoints 
sustained effectbof teratment in subjective parameters
Improvement in TNNS questionnaire
To develop easily approachable cost effeective treatment 
0th day ,8th day, 15th day 
sustained effect of treatment on subjective parameters
Improvement changes in TNNS questionnaire
To develop easily approachable cost effective treatment 
0th day ,8th day ,15th day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   An Open label double arm controlled clinical study to compare the efficacy of Shigru taila nasya with Shadbindhu Taila nasya in the management of Vataja pratisyaya - Nasal eosinophilia , age group of 20-40 years for a period 7 days.

During this time period , 40 participants will be recruited and devided  in to two groups 

Group A ( Trial group ) and Group B ( Control group) ,20  participants each.

Group A (Trial group ) 6 bindhu of Shigru taila Nasya will be instill to the nose of participants for 7 days.

Group B ( Control group ) 6 bindhu of Shadbindhu Tilam will be instill to the nose of participants for 7 days.

Clinical assesment will be done for both subjective and objective criteria on 0th day , 8th day and follow up on !5th day.

Statistical analysis will be done through data obtained on 0th day (BT) and 8th day (AT).


 
Close